PubRank

G Spurlock

Author PubWeight™ 38.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cheap, accurate and rapid allele frequency estimation of single nucleotide polymorphisms by primer extension and DHPLC in DNA pools. Hum Genet 2000 2.26
2 A full genome scan for late onset Alzheimer's disease. Hum Mol Genet 1999 2.26
3 Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry 2003 1.73
4 Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet 1996 1.64
5 Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry 2004 1.60
6 No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am J Psychiatry 1996 1.28
7 Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs). Hum Mutat 2008 1.25
8 A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere. J Med Genet 2006 1.14
9 Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet 2001 1.08
10 Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Mol Psychiatry 1998 1.00
11 Screening the human protocadherin 8 (PCDH8) gene in schizophrenia. Genes Brain Behav 2002 0.99
12 Autosome search for schizophrenia susceptibility genes in multiply affected families. Mol Psychiatry 1999 0.97
13 Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Eur Arch Psychiatry Clin Neurosci 1997 0.91
14 Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2003 0.87
15 CAG repeat length in the hKCa3 gene and symptom dimensions in schizophrenia. Biol Psychiatry 1999 0.86
16 A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol Psychiatry 1998 0.86
17 Association between PRODH and schizophrenia is not confirmed. Mol Psychiatry 2003 0.86
18 Mutation screening of the Homer gene family and association analysis in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2003 0.85
19 Distal spinal muscular atrophy with vocal cord paralysis (dSMA-VII) is not linked to the MPD2 locus on chromosome 5q31. J Med Genet 2000 0.82
20 Mutation screening and LD mapping in the VCFS deleted region of chromosome 22q11 in schizophrenia using a novel DNA pooling approach. Mol Psychiatry 2002 0.81
21 Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor. Mol Psychiatry 2002 0.81
22 Linkage study of chromosome 6p in sib-pairs with schizophrenia. Am J Med Genet 1997 0.80
23 Further support for an association between a polymorphic CAG repeat in the hKCa3 gene and schizophrenia. Mol Psychiatry 1998 0.80
24 Characterisation, mutation detection, and association analysis of alternative promoters and 5' UTRs of the human dopamine D3 receptor gene in schizophrenia. Mol Psychiatry 2002 0.79
25 Release of a sodium transport inhibitor (inhibitin) from cultured human cancer cells. Cancer Res 1986 0.79
26 Amyloid precursor protein mRNA levels in the mononuclear blood cells of Alzheimer's and Down's patients. Brain Res Mol Brain Res 1993 0.79
27 Identification of five novel SPRED1 germline mutations in Legius syndrome. Clin Genet 2011 0.79
28 Mutation screening of the KCNN3 gene reveals a rare frameshift mutation. Mol Psychiatry 2001 0.78
29 The high affinity neurotensin receptor gene (NTSR1): comparative sequencing and association studies in schizophrenia. Mol Psychiatry 2000 0.78
30 Bi-directional changes in the levels of messenger RNAs encoding gamma-aminobutyric acidA receptor alpha subunits after flurazepam treatment. Eur J Pharmacol 1992 0.78
31 Linkage studies of bipolar disorder with chromosome 18 markers. Am J Med Genet 1999 0.77
32 Amphetamine and vigabatrin down regulate aromatic L-amino acid decarboxylase mRNA levels. Brain Res Mol Brain Res 1996 0.76
33 Congenital disseminated neurofibromatosis type 1: a clinical and molecular case report. Am J Med Genet A 2008 0.76
34 No evidence for association between a non-synonymous polymorphism in the gene encoding human metabotropic glutamate receptor 7 and schizophrenia. Psychiatr Genet 2000 0.76
35 Characterization and partial purification of the sodium-potassium-ATPase inhibitor released from cultured rat hypothalamic cells. J Biol Chem 1985 0.76
36 Inhibitin: a specific inhibitor of sodium/sodium exchange in erythrocytes. J Clin Invest 1986 0.75
37 Lack of effect of antipsychotic and antidepressant drugs on glutamate receptor mRNA levels in rat brains. Neurosci Lett 1994 0.75
38 Problems and pitfalls in the isolation of an endogenous Na+, K+-ATPase inhibitor. Hypertension 1987 0.75
39 Comparative sequencing of the proneurotensin gene and association studies in schizophrenia. Mol Psychiatry 2000 0.75
40 A reproducible procedure for measuring sodium transport in cultured human fibroblasts from normal and obese donors. Clin Chim Acta 1985 0.75
41 Vasoreactive effects of hypothalamic sodium transport inhibitor. Prog Biochem Pharmacol 1988 0.75
42 Calcium retention and increased vascular reactivity caused by a hypothalamic sodium transport inhibitor. Clin Sci (Lond) 1988 0.75
43 Leukaemic promyelocytes and normal bone marrow cells release a passive sodium transport modifier (inhibitin). Clin Sci (Lond) 1985 0.75
44 Serum stimulation of sodium transport in human fibroblasts containing low and high levels of intracellular sodium. J Membr Biol 1986 0.75
45 Release of an active sodium transport inhibitor (ASTI) from rat hypothalamic cells in culture. Endocrinology 1984 0.75
46 Interaction of inhibitin with the human erythrocyte Na+(Li+)i/Nao+ exchanger. Biochim Biophys Acta 1989 0.75
47 Erythromycin binding studies on two different classes of antibiotic resistant mutant in Paramecium. FEBS Lett 1975 0.75
48 Sodium-potassium-ATPase and obesity. N Engl J Med 1984 0.75
49 No evidence for expanded polyglutamine sequences in bipolar disorder and schizophrenia. Mol Psychiatry 1998 0.75
50 Erythrocyte sodium pump activity in human obesity. Clin Chim Acta 1984 0.75
51 An active sodium transport inhibitor released from spontaneously hypertensive and normotensive rat fetal hypothalamic cells in culture. Am J Hypertens 1988 0.75
52 Relationship between red cell sodium transport, blood pressure, and family history of hypertension. Am J Hypertens 1988 0.75